Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

J Crowe
  • Vaccine, June 1995, Elsevier
  • DOI: 10.1016/0264-410x(94)00074-w

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/0264-410x(94)00074-w

The following have contributed to this page: Dr James E Crowe